← Evidence map

ArticleJournal of gastroenterology and hepatology2022

Gut microbiota-derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID-19: An open-label pilot study.

Lin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

38 papers cite it

2022
2023
2024
2025
2026
this papertrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 35170078